Should we offer preventive treatment to all carriers of PLN p.(Arg14del) variant? Pro: Provide pre-emptive treatment to asymptomatic carriers

被引:1
|
作者
de Boer, Rudolf A. [1 ]
机构
[1] Erasmus MC, Dept Cardiol, Rotterdam, Netherlands
关键词
CARDIOMYOPATHY;
D O I
10.1007/s12471-023-01793-0
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:287 / 288
页数:2
相关论文
共 4 条
  • [1] Should we offer preventive treatment to all carriers of PLN p.(Arg14del) variant?Pro: Provide pre-emptive treatment to asymptomatic carriers
    Rudolf A. de Boer
    Netherlands Heart Journal, 2023, 31 : 287 - 288
  • [2] Should we offer preventive treatment to all carriers of PLN p.(Arg14del) variant?Con: Do no harm to asymptomatic carriers
    Pieter A. Doevendans
    Netherlands Heart Journal, 2023, 31 : 289 - 290
  • [3] Should we offer preventive treatment to all carriers of PLN p.(Arg14del) variant? Con: Do no harm to asymptomatic carriers
    Doevendans, Pieter A. A.
    NETHERLANDS HEART JOURNAL, 2023, 31 (7-8) : 289 - 290
  • [4] Epicardial adipose tissue and malignant ventricular arrhythmias in phospholamban p.(Arg14del) variant carriers
    Mahmoud, Belend
    Cox, Moniek G. P. J.
    de Brouwer, Remco
    van der Heide, Myrthe Y. C.
    Gorter, Thomas M.
    Meems, Laura M. G.
    Wilde, Arthur A. M.
    van Veldhuisen, Dirk J.
    de Boer, Rudolf A.
    Westenbrink, B. Daan
    EUROPEAN HEART JOURNAL, 2025,